Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05066711 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NuVasive® ACP System Study

StatusEnrolling by Invitation
PhaseNot specified
SponsorNuVasive
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 22, 2025 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Notable Primary completion date: Jan 30, 2025 to Sep 30, 2026
    • Study completion date: Jan 30, 2026 to Jun 30, 2027
    v8
  2. Minor 2 versions Re-verified since Feb 16, 2024, no change to tracked fieldsv6-v7
  3. Minor Study sites: 2 to 3v5
  4. Minor Re-verified, no change to tracked fieldsv4
  5. Minor Study sites: 1 to 2v3
  6. Notable Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Start date changed from estimate of Jan 30, 2022 to May 22, 2022
    • Study sites: 0 to 1
    v2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
13 trials monitored
See all monitored trials
The primary objective of this study is to evaluate the safety and performance of anterior cervical spine surgery using the NuVasive anterior cervical plate (ACP) System as measured by reported complications, radiographic outcomes, and patient-reported outcomes (PROs).
Trial Details
NCT Number NCT05066711
Lead Sponsor NuVasive
Conditions
(from sponsor)
Cervical Spondylosis, Cervical Radiculopathy, Cervical Myelopathy, Cervical Disc Disease, Cervical Stenosis, Cervical Disc Herniation, Cervical Spine Disease
Related terms Radiculopathy, Spondylosis
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov